admin
birdflustocks.com »  admin
admin
SAB Biotherapeutics: Partnership with Naval Medical Research Center for SAB-176 study
By admin | |
SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a
Vir Biotechnology/GSK: Antibody cooperation ended
By admin | |
The partners have ended their collaboration on anti-influenza antibodies, freeing
BioNTech/CureVac: German court voids CureVac patent after BioNTech challenge, stock drops 41%
By admin | |
https://www.maucherjenkins.com/commentary/first-instance-declares-german-curevac-patent-on-mrna-vaccine-against-covid-19-invalid
GSK: GSK sells Haleon shares to sharpen its focus on vaccines and infectious diseases
By admin | |
GSK raises $1.1 billion from Haleon stake sale https://www.reuters.com/markets/deals/gsk-raises-886-mln-pounds-haleon-stake-sale-2023-10-06/
BioNTech/Pfizer: Pfizer and BioNTech resolve mRNA patent lawsuit filed by Promosome
By admin | |
No financial terms were disclosed. https://www.reuters.com/legal/pfizer-resolves-promosome-patent-lawsuit-over-covid-19-vaccine-2023-10-05/
Moderna: mRNA-1010 Seasonal Influenza Vaccine phase 3 study successfully completed
By admin | |
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-scale-down-manufacturing-covid-vaccine-2023-09-13/